Wockhardt Limited

Prashant Mandaogade

Girish Kumar Jain

Premchand Dalichandji Nakhat

Venkatesh Madhavacharya Joshi

Munish Talwar

Saurabh Srivastava

Vinayak Dinkar Kadam

Rahul Dabre

Cyril Estanove

François Pruvost

Roshanlal Sandal

The invention relates to self emulsifying drug delivery system based compositions of rhein or diacerein, or salts or esters or prodrugs thereof which are bioequivalent to a 50 mg diacerein formulation marketed under the trade name Art 50&#xae;. The compositions exhibit no variability in fed and fasted state conditions. The compositions also result in significant reduction in side effects such as, soft stools effects as compared to Art 50&#xae;. The invention also relates to methods for preparing such compositions.

Self-emulsifying pharmaceutical compositions of rhein or diacerein

The present invention relates to extended release dosage forms of metoprolol or salts thereof comprising a water insoluble and non-swellable inert core and one or more pharmaceutically acceptable excipients. The invention also relates to processes for the preparation of an inert core and extended release dosage forms.

Extended release dosage forms of metoprolol

The present invention relates to controlled release compositions of Zolpidem or pharmaceutically acceptable salts thereof adapted to release Zolpidem over a predetermined time period, according to a monophasic and/or a biphasic profile of dissolution. The present invention also relates to monolithic matrix based formulations of Zolpidem or pharmaceutically acceptable salts thereof.

Controlled release compositions containing zolpidem

The invention relates to pharmaceutical compositions comprising rhein or diacerein or salts or esters or prodrugs thereof, optionally with one or more pharmaceutically acceptable excipients. The invention also relates to the methods for preparing such compositions.

Rhein or diacerein compositions

Growing community of inventors

Amravati, India

Prashant Mandaogade